180 related articles for article (PubMed ID: 15809670)
1. The relationship between the androgen receptor CAG repeat polymorphism length and the response to intermittent androgen suppression therapy for advanced prostate cancer.
Klotz L; Correia A; Zhang W
Prostate Cancer Prostatic Dis; 2005; 8(2):179-83. PubMed ID: 15809670
[TBL] [Abstract][Full Text] [Related]
2. CAG polymorphic repeat length in androgen receptor gene combined with pretreatment serum testosterone level as prognostic factor in patients with metastatic prostate cancer.
Shimbo M; Suzuki H; Kamiya N; Imamoto T; Komiya A; Ueda T; Watanabe M; Shiraishi T; Ichikawa T
Eur Urol; 2005 Apr; 47(4):557-63. PubMed ID: 15774258
[TBL] [Abstract][Full Text] [Related]
3. Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression.
Nam RK; Elhaji Y; Krahn MD; Hakimi J; Ho M; Chu W; Sweet J; Trachtenberg J; Jewett MA; Narod SA
J Urol; 2000 Aug; 164(2):567-72. PubMed ID: 10893645
[TBL] [Abstract][Full Text] [Related]
4. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
[TBL] [Abstract][Full Text] [Related]
5. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.
Bratt O; Borg A; Kristoffersson U; Lundgren R; Zhang QX; Olsson H
Br J Cancer; 1999 Oct; 81(4):672-6. PubMed ID: 10574254
[TBL] [Abstract][Full Text] [Related]
6. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?
Zeegers MP; Kiemeney LA; Nieder AM; Ostrer H
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1765-71. PubMed ID: 15533905
[TBL] [Abstract][Full Text] [Related]
7. Influence of number of CAG repeats on local control in the RTOG 86-10 protocol.
Abdel-Wahab M; Berkey BA; Krishan A; O'Brien T; Hammond E; Roach M; Lawton C; Pilepich M; Markoe A; Pollack A
Am J Clin Oncol; 2006 Feb; 29(1):14-20. PubMed ID: 16462497
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor polymorphisms and the incidence of prostate cancer.
Chen C; Lamharzi N; Weiss NS; Etzioni R; Dightman DA; Barnett M; DiTommaso D; Goodman G
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1033-40. PubMed ID: 12376504
[TBL] [Abstract][Full Text] [Related]
9. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
[TBL] [Abstract][Full Text] [Related]
10. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?
Mishra D; Thangaraj K; Mandhani A; Kumar A; Mittal R
Clin Genet; 2005 Jul; 68(1):55-60. PubMed ID: 15952987
[TBL] [Abstract][Full Text] [Related]
11. In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors.
Tsujimoto Y; Takakuwa T; Takayama H; Nishimura K; Okuyama A; Aozasa K; Nonomura N
Prostate; 2004 Feb; 58(3):283-90. PubMed ID: 14743468
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor CAG polymorphism and prostate cancer risk.
Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk.
Andersson P; Varenhorst E; Söderkvist P
Eur J Cancer; 2006 Nov; 42(16):2833-7. PubMed ID: 17010601
[TBL] [Abstract][Full Text] [Related]
14. Somatic mosaicism and cancer: a micro-genetic examination into the role of the androgen receptor gene in prostate cancer.
Alvarado C; Beitel LK; Sircar K; Aprikian A; Trifiro M; Gottlieb B
Cancer Res; 2005 Sep; 65(18):8514-8. PubMed ID: 16166332
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor CAG repeat length contraction in diseased and non-diseased prostatic tissues.
Sircar K; Gottlieb B; Alvarado C; Aprikian A; Beitel LK; Alam-Fahmy M; Begin L; Trifiro M
Prostate Cancer Prostatic Dis; 2007; 10(4):360-8. PubMed ID: 17440439
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients.
Strom SS; Gu Y; Zhang H; Troncoso P; Babaian RJ; Pettaway CA; Shete S; Spitz MR; Logothetis CJ
Prostate; 2004 Sep; 60(4):343-51. PubMed ID: 15264247
[TBL] [Abstract][Full Text] [Related]
17. Somatic mosaicism of androgen receptor CAG repeats in colorectal carcinoma epithelial cells from men.
Di Fabio F; Alvarado C; Gologan A; Youssef E; Voda L; Mitmaker E; Beitel LK; Gordon PH; Trifiro M
J Surg Res; 2009 Jun; 154(1):38-44. PubMed ID: 19062046
[TBL] [Abstract][Full Text] [Related]
18. Associations between androgen receptor CAG repeat length and sperm morphology.
Milatiner D; Halle D; Huerta M; Margalioth EJ; Cohen Y; Ben-Chetrit A; Gal M; Mimoni T; Eldar-Geva T
Hum Reprod; 2004 Jun; 19(6):1426-30. PubMed ID: 15117901
[TBL] [Abstract][Full Text] [Related]
19. Length of androgen receptor-CAG repeats in fertile and infertile Egyptian men.
Badran WA; Fahmy I; Abdel-Megid WM; Elder K; Mansour R; Kent-First M
J Androl; 2009; 30(4):416-25. PubMed ID: 19168451
[TBL] [Abstract][Full Text] [Related]
20. [CAG microsatellite polymorphisms of androgen receptor gene and the stage and grade of prostate cancer].
Li C; Dong J; Guan W
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):217-9. PubMed ID: 11783090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]